Base de dados : MEDLINE
Pesquisa : N03.349.650.270 [Categoria DeCS]
Referências encontradas : 132 [refinar]
Mostrando: 1 .. 10   no formato [Detalhado]

página 1 de 14 ir para página                         

  1 / 132 MEDLINE  
              next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28114538
[Au] Autor:Butler SM
[Ad] Endereço:Stuart M. Butler, PhD, is a senior fellow, Economic Studies, at the Brookings Institution in Washington, DC, where he focuses on developing new policy ideas. He is also an adjunct professor at Georgetown University's Graduate School, and serves on the board of trustees for the Convergence Center for Policy Resolution.
[Ti] Título:Repeal and Replace Obamacare: What Could It Mean?
[So] Source:JAMA;317(3):244-245, 2017 01 17.
[Is] ISSN:1538-3598
[Cp] País de publicação:United States
[La] Idioma:eng
[Mh] Termos MeSH primário: Medicaid
Patient Protection and Affordable Care Act
Política
[Mh] Termos MeSH secundário: Trocas de Seguro de Saúde/economia
Trocas de Seguro de Saúde/legislação & jurisprudência
Planos de Sistemas de Saúde/economia
Seres Humanos
Medicaid/economia
Medicaid/legislação & jurisprudência
Poupança para Cobertura de Despesas Médicas/organização & administração
Patient Protection and Affordable Care Act/economia
Patient Protection and Affordable Care Act/legislação & jurisprudência
Governo Estadual
Estados Unidos
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Em] Mês de entrada:1702
[Cu] Atualização por classe:170213
[Lr] Data última revisão:
170213
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:170124
[St] Status:MEDLINE
[do] DOI:10.1001/jama.2016.19918


  2 / 132 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:27477567
[Au] Autor:Yelin E; Yazdany J; Trupin L
[Ad] Endereço:The Rosalind Russell/Ephraim P. Engleman Rheumatology Research Center and the Philip R. Lee Institute for Health Policy Studies, University of California, San Francisco.
[Ti] Título:Relationship Between Process of Care and a Subsequent Increase in Damage in Systemic Lupus Erythematosus.
[So] Source:Arthritis Care Res (Hoboken);69(6):927-932, 2017 Jun.
[Is] ISSN:2151-4658
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:OBJECTIVE: To evaluate whether low ratings of interactions with providers and health plans in 2013 were associated with increased systemic lupus erythematosus (SLE) damage in 2015. METHODS: Data were derived from the Lupus Outcomes Study (LOS) annual surveys and include items from the Consumer Assessment of Health Plans and Interpersonal Processes of Care Scale measuring dimensions of health care interactions. We used ordinary least squares regression to model the change in disease damage over a 2-year period, 2013-2015, as a function of ratings of multiple dimensions of interactions with providers and health plans, with and without adjustment for demographic characteristics, socioeconomic status, and SLE and overall health status, and logistic regression to estimate the effect of the same matrix of variables on the probability of experiencing a minimum clinically important increase in damage. RESULTS: There were 566 LOS respondents who were followed from 2013-2015 and who rated their providers and health plans in 2013. After adjustment, persons with SLE rating their providers poorly in patient-provider communication experienced a significantly greater accrual of disease damage (odds ratio [OR] 0.23 [95% confidence interval (95% CI) 0.09-0.38]) and were more likely to experience a minimum clinically important increase in damage (OR 2.35 [95% CI 1.25-4.39]). After adjustment, those rating their health plan poorly on care coordination experienced a significantly greater accrual of disease damage (OR 0.19 [95% CI 0.03-0.35]) and were more likely to experience a minimum clinically important increase in damage (OR 2.20 [95% CI 1.12-4.34]). CONCLUSION: Poor patient-provider communication and care coordination may result in increased disease damage.
[Mh] Termos MeSH primário: Assistência à Saúde/normas
Pessoal de Saúde/normas
Planos de Sistemas de Saúde/normas
Lúpus Eritematoso Sistêmico/diagnóstico
Lúpus Eritematoso Sistêmico/terapia
[Mh] Termos MeSH secundário: Adulto
Idoso
Feminino
Seres Humanos
Masculino
Meia-Idade
Inquéritos e Questionários/normas
Adulto Jovem
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Em] Mês de entrada:1708
[Cu] Atualização por classe:170816
[Lr] Data última revisão:
170816
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:160802
[St] Status:MEDLINE
[do] DOI:10.1002/acr.22977


  3 / 132 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:27199018
[Au] Autor:Newton J; Dooris M; Wills J
[Ad] Endereço:London South Bank University - School of Health and Social Care, United Kingdom.
[Ti] Título:Healthy universities: an example of a whole-system health-promoting setting.
[So] Source:Glob Health Promot;23(1 Suppl):57-65, 2016 Mar.
[Is] ISSN:1757-9767
[Cp] País de publicação:England
[La] Idioma:eng
[Ab] Resumo:The health-promoting settings approach is well established in health promotion, with organisational settings being understood as complex systems able to support human wellbeing and flourishing. Despite the reach and evident importance of higher education as a sector, 'healthy universities' has not received high-level international leadership comparable to many other settings programmes. This study explores how the concept of a healthy university is operationalised in two case study universities. Data collection methods included documentary analysis, observation field notes and semi-structured interviews with staff and students. Staff and students understood the characteristics of a healthy university to pertain to management processes relating to communication and to a respectful organisational ethos. Enhancers of health and wellbeing were feeling valued, being listened to, having skilled and supportive line managers and having a positive physical environment. Inhibitors of health and wellbeing were having a sense of powerlessness and a lack of care and concern. The concept of the healthy university has been slow to be adopted in contrast to initiatives such as healthy schools. In addition to challenges relating to lack of theorisation, paucity of evidence and difficulties in capturing the added value of whole-system working, this study suggests that this may be due to both their complex organisational structure and the diverse goals of higher education, which do not automatically privilege health and wellbeing. It also points to the need for a whole-university approach that pays attention to the complex interactions and interconnections between component parts and highlights how the organisation can function effectively as a social system.
[Mh] Termos MeSH primário: Promoção da Saúde/métodos
Planos de Sistemas de Saúde/normas
Estudantes
Universidades/organização & administração
[Mh] Termos MeSH secundário: Promoção da Saúde/organização & administração
Seres Humanos
Serviços de Saúde Escolar/organização & administração
Estudantes/estatística & dados numéricos
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Em] Mês de entrada:1710
[Cu] Atualização por classe:171019
[Lr] Data última revisão:
171019
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:160521
[St] Status:MEDLINE
[do] DOI:10.1177/1757975915601037


  4 / 132 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
PubMed Central Texto completo
Texto completo
[PMID]:27179509
[Au] Autor:Zhou X; Yap P; Tanner M; Bergquist R; Utzinger J; Zhou XN
[Ad] Endereço:Department of Parasitology, Medical College of Soochow University, No. 199 Renai Road, Suzhou, 215123, People's Republic of China.
[Ti] Título:Surveillance and response systems for elimination of tropical diseases: summary of a thematic series in Infectious Diseases of Poverty.
[So] Source:Infect Dis Poverty;5(1):49, 2016 May 14.
[Is] ISSN:2049-9957
[Cp] País de publicação:England
[La] Idioma:eng
[Ab] Resumo:The peer-reviewed journal Infectious Diseases of Poverty provides a new platform to engage with, and disseminate in an open-access format, science outside traditional disciplinary boundaries. The current piece reviews a thematic series on surveillance-response systems for elimination of tropical diseases. Overall, 22 contributions covering a broad array of diseases are featured - i.e. clonorchiasis, dengue, hepatitis, human immunodeficiency virus/acquired immune deficiency syndrome (HIV/AIDS), H7N9 avian influenza, lymphatic filariasis, malaria, Middle East respiratory syndrome (MERS), rabies, schistosomiasis and tuberculosis (TB). There are five scoping reviews, a commentary, a letter to the editor, an opinion piece and an editorial pertaining to the theme "Elimination of tropical disease through surveillance and response". The remaining 13 articles are original contributions mainly covering (i) drug resistance; (ii) innovation and validation in the field of mathematical modelling; (iii) elimination of infectious diseases; and (iv) social media reports on disease outbreak notifications released by national health authorities. Analysis of the authors' affiliations reveals that scientists from the People's Republic of China (P.R. China) are prominently represented. Possible explanations include the fact that the 2012 and 2014 international conferences pertaining to surveillance-response mechanisms were both hosted by the National Institute of Parasitic Diseases (NIPD) in Shanghai, coupled with P.R. China's growing importance with regard to the control of infectious diseases. Within 4 to 22 months of publication, three of the 22 contributions were viewed more than 10 000 times each. With sustained efforts focusing on relevant and strategic information towards control and elimination of infectious diseases, Infectious Diseases of Poverty has become a leading journal in the field of surveillance and response systems in infectious diseases and beyond.
[Mh] Termos MeSH primário: Doenças Transmissíveis/epidemiologia
Controle de Infecções/métodos
Pobreza
Vigilância em Saúde Pública/métodos
[Mh] Termos MeSH secundário: Animais
China/epidemiologia
Surtos de Doenças/prevenção & controle
Planos de Sistemas de Saúde
Seres Humanos
Doenças Parasitárias
Mídias Sociais
Medicina Tropical/economia
Medicina Tropical/métodos
[Pt] Tipo de publicação:EDITORIAL; REVIEW
[Em] Mês de entrada:1702
[Cu] Atualização por classe:170220
[Lr] Data última revisão:
170220
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:160516
[St] Status:MEDLINE
[do] DOI:10.1186/s40249-016-0144-7


  5 / 132 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:27126827
[Au] Autor:Habibi M; Kuttab HM
[Ad] Endereço:Department of Pharmacy Practice, University of Illinois at Chicago, Chicago, IL mhabib1@uic.edu.
[Ti] Título:Management of multiple sclerosis and the integration of related specialty pharmacy programs within health systems.
[So] Source:Am J Health Syst Pharm;73(11):811-9, 2016 Jun 01.
[Is] ISSN:1535-2900
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:PURPOSE: The management of multiple sclerosis (MS) and the integration of related specialty pharmacy programs within health systems are discussed. SUMMARY: MS is a progressive immune-mediated inflammatory disease of the central nervous system. Current treatment strategies include the use of disease-modifying therapies (DMTs) that have various degrees of efficacy and tolerability. These DMTs also differ with respect to frequency and route of administration, which can significantly impact patient compliance and ultimately their response to therapy. The introduction of oral and injectable DMTs requiring less-frequent injections and having better adverse-effect profiles may help patients improve adherence to therapy; however, access to these therapies is often restricted due to both their high cost and limited distribution. These DMTs include fingolimod, teriflunomide, dimethyl fumarate, and pegylated interferon beta-1a. All others, with the exception of fingolimod, have limited distribution. Pharmacists in health-system pharmacy programs can play a significant role in assisting patients with MS manage their disease efficiently and safely by educating them about their therapies, ensuring compliance with the associated risk evaluation and mitigation strategy (REMS) program, and helping them access these therapies in a timely manner. CONCLUSION: MS is a progressive neurologic disorder that requires lifelong treatment with DMTs. Good compliance, compliance with the associated REMS program, and timely access to these drugs may positively influence patient care and outcomes and provide an opportunity for the health-system pharmacists to have a active role in caring for these patients.
[Mh] Termos MeSH primário: Gerenciamento Clínico
Planos de Sistemas de Saúde
Imunossupressores/administração & dosagem
Esclerose Múltipla/tratamento farmacológico
Serviço de Farmácia Hospitalar/métodos
[Mh] Termos MeSH secundário: Centros Médicos Acadêmicos/métodos
Centros Médicos Acadêmicos/tendências
Crotonatos/administração & dosagem
Cloridrato de Fingolimode/administração & dosagem
Planos de Sistemas de Saúde/tendências
Seres Humanos
Esclerose Múltipla/diagnóstico
Serviço de Farmácia Hospitalar/tendências
Toluidinas/administração & dosagem
[Pt] Tipo de publicação:JOURNAL ARTICLE; REVIEW
[Nm] Nome de substância:
0 (Crotonates); 0 (Immunosuppressive Agents); 0 (Toluidines); 1C058IKG3B (teriflunomide); G926EC510T (Fingolimod Hydrochloride)
[Em] Mês de entrada:1701
[Cu] Atualização por classe:170120
[Lr] Data última revisão:
170120
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:160430
[St] Status:MEDLINE
[do] DOI:10.2146/ajhp150723


  6 / 132 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:26522185
[Au] Autor:Phua KH; Sheikh K; Tang SL; Lin V
[Ad] Endereço:National University of Singapore, Lee Kuan Yew School of Public Policy, Oei Tiong Ham Building, Level 2M, 469C Bukit Timah Road, Singapore 259772, Singapore. Electronic address: spppkh@nus.edu.sg.
[Ti] Título:Editorial - Health Systems of Asia: Equity, Governance and Social Impact.
[So] Source:Soc Sci Med;145:141-4, 2015 Nov.
[Is] ISSN:1873-5347
[Cp] País de publicação:England
[La] Idioma:eng
[Mh] Termos MeSH primário: Programas Governamentais/economia
Planos de Sistemas de Saúde/economia
Mudança Social
[Mh] Termos MeSH secundário: Ásia
Países em Desenvolvimento
Disparidades em Assistência à Saúde/economia
Seres Humanos
[Pt] Tipo de publicação:CONGRESSES; EDITORIAL
[Em] Mês de entrada:1605
[Cu] Atualização por classe:151102
[Lr] Data última revisão:
151102
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:151103
[St] Status:MEDLINE


  7 / 132 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
PubMed Central Texto completo
Texto completo
[PMID]:26042935
[Au] Autor:Weaver MS; Yao AJ; Renner LA; Harif M; Lam CG
[Ad] Endereço:Department of Oncology, St Jude Children's Research Hospital, 262 Danny Thomas Place, MS 721, Memphis, TN 38105, USA.
[Ti] Título:The prioritisation of paediatrics and palliative care in cancer control plans in Africa.
[So] Source:Br J Cancer;112(12):1845-56, 2015 Jun 09.
[Is] ISSN:1532-1827
[Cp] País de publicação:England
[La] Idioma:eng
[Ab] Resumo:BACKGROUND: Given the burden of childhood cancer and palliative care need in Africa, this paper investigated the paediatric and palliative care elements in cancer control plans. METHODS: We conducted a comparative content analysis of accessible national cancer control plans in Africa, using a health systems perspective attentive to context, development, scope, and monitoring/evaluation. Burden estimates were derived from World Bank, World Health Organisation, and Worldwide Palliative Care Alliance. RESULTS: Eighteen national plans and one Africa-wide plan (10 English, 9 French) were accessible, representing 9 low-, 4 lower-middle-, and 5 upper-middle-income settings. Ten plans discussed cancer control in the context of noncommunicable diseases. Paediatric cancer was mentioned in 7 national plans, representing 5127 children, or 13% of the estimated continental burden for children aged 0-14 years. Palliative care needs were recognised in 11 national plans, representing 157 490 children, or 24% of the estimated Africa-wide burden for children aged 0-14 years; four plans specified paediatric palliative needs. Palliative care was itemised in four budgets. Sample indicators and equity measures were identified, including those highlighting contextual needs for treatment access and completion. CONCLUSIONS: Recognising explicit strategies and funding for paediatric and palliative services may guide prioritised cancer control efforts in resource-limited settings.
[Mh] Termos MeSH primário: Política de Saúde
Planos de Sistemas de Saúde
Neoplasias/terapia
Cuidados Paliativos/métodos
Planejamento de Assistência ao Paciente
[Mh] Termos MeSH secundário: Adolescente
África
Criança
Pré-Escolar
Assistência à Saúde
Feminino
Seres Humanos
Lactente
Masculino
Neoplasias/prevenção & controle
Cuidados Paliativos/normas
Pediatria/métodos
Pediatria/normas
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Em] Mês de entrada:1509
[Cu] Atualização por classe:160609
[Lr] Data última revisão:
160609
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:150605
[St] Status:MEDLINE
[do] DOI:10.1038/bjc.2015.158


  8 / 132 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:26003160
[Au] Autor:Baranowski PJ; Peterson KL; Statz-Paynter JL; Zorek JA
[Ti] Título:Incidence and cost of medications dispensed despite electronic medical record discontinuation.
[So] Source:J Am Pharm Assoc (2003);55(3):313-9, 2015 May-Jun.
[Is] ISSN:1544-3450
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:OBJECTIVE: To determine the incidence and cost of medications dispensed despite discontinuation (MDDD) of the medications in the electronic medical record within an integrated health care organization. SETTING: Dean Health System, with medical clinics and pharmacies linked by an electronic medical record, and a shared health plan and pharmacy benefits management company. PRACTICE DESCRIPTION: Pharmacist-led quality improvement project using retrospective chart review. PRACTICE INNOVATION: Electronic medical records, pharmacy records, and prescription claims data from patients 18 years of age or older who had a prescription filled for a chronic condition from June 2012 to August 2013 and submitted a claim through the Dean Health Plan were aggregated and cross-referenced to identify MDDD. MAIN OUTCOME MEASURES: Descriptive statistics were used to characterize demographics and MDDD incidence. Fisher's exact test and independent samples t tests were used to compare MDDD and non-MDDD groups. Wholesale acquisition cost was applied to each MDDD event. RESULTS: 7,406 patients met inclusion criteria. For 223 (3%) patients with MDDD, 253 independent events were identified. In terms of frequency per category, antihypertensive agents topped the list, followed, in descending order, by anticonvulsants, antilipemics, antidiabetics, and anticoagulants. Nine medications accounted for 59% (150 of 253) of all MDDD events; these included (again in descending order): gabapentin, atorvastatin, simvastatin, hydrochlorothiazide, lisinopril, warfarin, furosemide, metformin, and metoprolol. Mail-service pharmacies accounted for the highest incidence (5.3%) of MDDD, followed by mass merchandisers (4.6%) and small chains (3.9%). The total cost attributable to MDDD was $9,397.74. CONCLUSION: Development of a technology-based intervention to decrease the incidence of MDDD may be warranted to improve patient safety and decrease health care costs.
[Mh] Termos MeSH primário: Custos de Medicamentos/estatística & dados numéricos
Registros Eletrônicos de Saúde
Planos de Sistemas de Saúde/economia
[Mh] Termos MeSH secundário: Prescrição Eletrônica/economia
Feminino
Seres Humanos
Masculino
Meia-Idade
Melhoria de Qualidade
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Em] Mês de entrada:1512
[Cu] Atualização por classe:150525
[Lr] Data última revisão:
150525
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:150525
[St] Status:MEDLINE
[do] DOI:10.1331/JAPhA.2015.14154


  9 / 132 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:25896265
[Au] Autor:Boekhout AH; Maunsell E; Pond GR; Julian JA; Coyle D; Levine MN; Grunfeld E; FUPII Trial Investigators
[Ad] Endereço:Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada. a.boekhout@nki.nl.
[Ti] Título:A survivorship care plan for breast cancer survivors: extended results of a randomized clinical trial.
[So] Source:J Cancer Surviv;9(4):683-91, 2015 Dec.
[Is] ISSN:1932-2267
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:PURPOSE: Prevailing wisdom suggests that implementation of a survivorship care plan (SCP) will address deficits in survivorship care planning and delivery for cancer patients. Here, we present 24-month results of a randomized clinical trial on health service and patient-reported outcomes among breast cancer patients transferred to their primary care physician for follow-up care. The 24-month assessments represent the long-term benefit and sustainability of the implantation of a SCP. METHODS: In all, 408 patients with early-stage breast cancer were randomized to the SCP or control group. Patient self-completed questionnaires, supplemented with telephone interviews, during the 24-month study period assessed health service and patient-reported outcomes. The primary outcome was cancer-specific distress. Secondary outcomes included health-related quality of life, patient satisfaction, continuity and coordination of care, and health service outcomes such as adherence to guidelines. RESULTS: Over the course of 24 months, there were no differences between both groups in health service and patient-reported outcomes. Women from Quebec compared to those from Western Canada (p < 0.001), women within 2 years of completion of primary treatment compared to a longer period (p = 0.013), and those with a higher SF-36 mental component score compared to a lower score (p = 0.044) were positively associated with adherence to guidelines. CONCLUSION: The implementation of a SCP in the transition of survivorship care from cancer center to primary care did not contribute to improved health service or patient-reported outcomes in this study population. Therefore, additional research is needed before widespread implementation of a SCP in clinical practice. IMPLICATIONS OF CANCER SURVIVORS: The transition of survivorship care from cancer center to the primary care setting showed no negative effect on health service and patient-reported outcomes.
[Mh] Termos MeSH primário: Neoplasias da Mama/reabilitação
Continuidade da Assistência ao Paciente/organização & administração
Planos de Sistemas de Saúde
Sobreviventes
[Mh] Termos MeSH secundário: Adulto
Idoso
Idoso de 80 Anos ou mais
Neoplasias da Mama/mortalidade
Canadá/epidemiologia
Feminino
Seguimentos
Planos de Sistemas de Saúde/normas
Seres Humanos
Meia-Idade
Satisfação do Paciente/estatística & dados numéricos
Atenção Primária à Saúde/organização & administração
Atenção Primária à Saúde/normas
Qualidade de Vida
Quebeque/epidemiologia
Inquéritos e Questionários
Sobreviventes/estatística & dados numéricos
[Pt] Tipo de publicação:JOURNAL ARTICLE; RANDOMIZED CONTROLLED TRIAL; RESEARCH SUPPORT, NON-U.S. GOV'T
[Em] Mês de entrada:1608
[Cu] Atualização por classe:171105
[Lr] Data última revisão:
171105
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:150422
[St] Status:MEDLINE
[do] DOI:10.1007/s11764-015-0443-1


  10 / 132 MEDLINE  
              first record previous record
seleciona
para imprimir
Fotocópia
PubMed Central Texto completo
Texto completo
[PMID]:25711999
[Au] Autor:American College of Medical Toxicology; American Academy of Clinical Toxicology
[Ti] Título:Antidote shortages in the USA: impact and response.
[So] Source:J Med Toxicol;11(1):144-6, 2015 Mar.
[Is] ISSN:1937-6995
[Cp] País de publicação:United States
[La] Idioma:eng
[Mh] Termos MeSH primário: Antídotos/provisão & distribuição
Antivenenos
Indústria Farmacêutica
Planos de Sistemas de Saúde
Legislação de Medicamentos
[Mh] Termos MeSH secundário: Antídotos/efeitos adversos
Antídotos/química
Antídotos/economia
Antivenenos/efeitos adversos
Antivenenos/química
Antivenenos/economia
Química Farmacêutica/economia
Indústria Farmacêutica/economia
Indústria Farmacêutica/legislação & jurisprudência
Estabilidade de Medicamentos
Armazenamento de Medicamentos
Guias como Assunto
Planos de Sistemas de Saúde/legislação & jurisprudência
Seres Humanos
Produção de Droga sem Interesse Comercial/economia
Sociedades Médicas
Toxicologia/recursos humanos
Estados Unidos
United States Food and Drug Administration
[Pt] Tipo de publicação:JOURNAL ARTICLE; RESEARCH SUPPORT, NON-U.S. GOV'T
[Nm] Nome de substância:
0 (Antidotes); 0 (Antivenins)
[Em] Mês de entrada:1512
[Cu] Atualização por classe:160301
[Lr] Data última revisão:
160301
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:150226
[St] Status:MEDLINE
[do] DOI:10.1007/s13181-013-0372-1



página 1 de 14 ir para página                         
   


Refinar a pesquisa
  Base de dados : MEDLINE Formulário avançado   

    Pesquisar no campo  
1  
2
3
 
           



Search engine: iAH v2.6 powered by WWWISIS

BIREME/OPAS/OMS - Centro Latino-Americano e do Caribe de Informação em Ciências da Saúde